Related Experiment Video
Updated: Jan 17, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Analysis of Adverse Events in Medical Devices for Diabetes
Mariana Ribeiro Brandão1, Jefferson Luiz Brum Marques1, Renato Garcia Ojeda1
1Institute of Biomedical Engineering (IEB-UFSC), Federal University of Santa Catarina, Florianópolis, Brazil.
This study analyzed adverse events from diabetes monitoring devices like blood glucose monitors (BGM), continuous glucose monitoring (CGM), and insulin pumps. Key issues identified were hypoglycemia and hyperglycemia, emphasizing the need for improved user-centered technologies and reporting practices.
Area of Science:
- Medical Device Technology
- Patient Safety
- Diabetes Management
Background:
- Home-use medical devices are crucial for diabetes management.
- Identifying adverse events and their causes is essential for patient safety.
- Focus on devices for blood glucose monitoring and insulin delivery.
Purpose of the Study:
- To identify adverse events associated with home-use medical devices for diabetes patients.
- To categorize the probable causes of these adverse events.
- To propose strategies for mitigating identified risks.
Main Methods:
- Utilized technovigilance alert databases from Brazil (ANVISA) and the USA (MAUDE-FDA).
- Analyzed data from January 2019 to December 2024.
- Included blood glucose monitors (BGM), continuous glucose monitoring systems (CGM), and insulin pumps.
Main Results:
- Significant notification volumes for BGM (52,601), CGM (1,624,664), and insulin pumps (1,339,652) were recorded.
- Adverse event mitigation strategies addressed human, technological, and environmental factors.
- Hypoglycemia and hyperglycemia were the primary patient-reported issues.
Conclusions:
- Encouraging adverse event reporting is vital for evidence generation.
- Strategies include developing user-centered, accessible, and reliable technologies within an interdisciplinary framework.
- Interconnectivity and lifecycle management are key for ubiquitous technological process management.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Errors occurring during blood pressure monitoring
Several factors...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

